XML 29 R20.htm IDEA: XBRL DOCUMENT
v3.23.3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES | Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share the three and nine months ended September 30, 2023 and 2022 because the effect of their inclusion would have been anti-dilutive. SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES
|  | For the three and nine months ended September 30, 2023 |  |  | For the three and nine months ended September 30, 2022 |
Warrants to purchase shares of common stock |  |  | 609,893 |  |  |  | 655,463 |
Restricted stock units - vested and unissued |  |  | 20,847 |  |  |  | 61,428 |
Restricted stock units - unvested |  |  | 148,251 |  |  |  | 65,117 |
Restricted stock awards - vested and unissued |  |  | — |  |  |  | 974 |
Investment options to purchase shares of common stock |  |  | 1,070,000 |  |  |  | 1,070,000 |
Options to purchase shares of common stock |  |  | 31,852 |  |  |  | 22,829 |
Total potentially dilutive securities |  |  | 1,880,843 |  |  |  | 1,875,811 |
SCHEDULE OF FAIR VALUE HIERARCHY OF VALUATION INPUTS ON RECURRING BASIS | The following table provides the financial liabilities measured on a recurring basis and reported at fair value on the balance sheet as of September 30, 2023, and December 31, 2022, and indicates the fair value of the valuation inputs the Company utilized to determine such fair value of warrant liabilities, derivative liability, and investment options: SCHEDULE OF FAIR VALUE HIERARCHY OF VALUATION INPUTS ON RECURRING BASIS
|  | Level |  | September 30, 2023 |  |  | December 31, 2022 |
Warrant liabilities - January 2021 Warrants |  | 3 |  | $ | 18 |  |  | $ | 81 |
Warrant liabilities - February 2021 Warrants |  | 3 |  |  | 59 |  |  |  | 79 |
Warrant liabilities - February 2022 Warrants |  | 3 |  |  | 300,480 |  |  |  | 185,055 |
Fair value of warrant liability |  |  |  | $ | 300,557 |  |  | $ | 185,215 |
ENVERIC BIOSCIENCES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|  | Level |  | September 30, 2023 |  |  | December 31, 2022 |
Derivative liability - May 2022 |  | 3 |  | $ | — |  |  | $ | 727,000 |
Fair value of derivative liability |  |  |  | $ | — |  |  | $ | 727,000 |
|  | Level |  | September 30, 2023 |  |  | December 31, 2022 |
H.C. Wainwright & Co., LLC investment options |  | 3 |  | $ | 70,521 |  |  | $ | 44,904 |
RD investment options |  | 3 |  |  | 442,653 |  |  |  | 302,289 |
PIPE investment options |  | 3 |  |  | 737,755 |  |  |  | 503,815 |
Fair value of investment option liability |  |  |  | $ | 1,250,929 |  |  | $ | 851,008 |
Subsequent Measurement [Member] |
SCHEDULE OF FAIR VALUE OF WARRANT LIABILITIES AND DERIVATIVE LIABILITY AND INVESTMENT OPTIONS | The following table presents the changes in fair value of the warrant liabilities, derivative liability, and investment options that are classified as Level 3: SCHEDULE OF FAIR VALUE OF WARRANT LIABILITIES AND DERIVATIVE LIABILITY AND INVESTMENT OPTIONS
|  | Total Warrant Liabilities |
Fair value as of December 31, 2022 |  | $ | 185,215 |
Change in fair value |  |  | 115,342 |
Fair value as of September 30, 2023 |  | $ | 300,557 |
|  | Total Derivative Liability |
Fair value as of December 31, 2022 |  | $ | 727,000 |
Change in fair value arising from redemption of Akos Series A Preferred Stock - See Note 8 |  |  | (727,000 | )
Fair value of derivative liability as of September 30, 2023 |  | $ | — |
|  | Total Investment Option Liability |
Fair value as of December 31, 2022 |  | $ | 851,008 |
Change in fair value |  |  | 399,921 |
Fair value of investment option liability as of September 30, 2023 |  | $ | 1,250,929 |
SCHEDULE OF BLACK SCHOLES VALUATION MODELS OF WARRANT LIABILITIES AND INVESTMENT OPTIONS | The key inputs into the Black Scholes valuation model for the Level 3 valuations of the warrant liabilities as of September 30, 2023 are below: SCHEDULE OF BLACK SCHOLES VALUATION MODELS OF WARRANT LIABILITIES AND INVESTMENT OPTIONS
|  | January 2021 Warrants |  |  | February 2021 Warrants |  |  | February 2022 Warrants |  |  | February 2022 Post-Modification Warrants |
Term (years) |  |  | 2.3 |  |  |  | 2.4 |  |  |  | 3.4 |  |  |  | 4.3 |
Stock price |  | $ | 2.38 |  |  | $ | 2.38 |  |  | $ | 2.38 |  |  | $ | 2.38 |
Exercise price |  | $ | 247.50 |  |  | $ | 245.00 |  |  | $ | 27.50 |  |  | $ | 7.78 |
Dividend yield |  |  | — | % |  |  | — | % |  |  | — | % |  |  | — | %
Expected volatility |  |  | 80.0 | % |  |  | 85.0 | % |  |  | 96.0 | % |  |  | 94.0 | %
Risk free interest rate |  |  | 5.00 | % |  |  | 4.90 | % |  |  | 4.80 | % |  |  | 4.70 | %
Number of warrants |  |  | 36,429 |  |  |  | 34,281 |  |  |  | 338,000 |  |  |  | 122,000 |
Value (per share) |  | $ | — |  |  | $ | — |  |  | $ | 0.46 |  |  | $ | 1.18 |
The key inputs into the Black Scholes valuation model for the Level 3 valuations of the investment options as of September 30, 2023 are below:
|  | H.C. Wainwright & Co., LLC Options |  |  | RD Offering Options |  |  | PIPE Offering Options |
Term (years) |  |  | 3.8 |  |  |  | 4.3 |  |  |  | 4.3 |
Stock price |  | $ | 2.38 |  |  | $ | 2.38 |  |  | $ | 2.38 |
Exercise price |  | $ | 10.00 |  |  | $ | 7.78 |  |  | $ | 7.78 |
Dividend yield |  |  | — | % |  |  | — | % |  |  | — | %
Expected volatility |  |  | 97.0 | % |  |  | 94.0 | % |  |  | 94.0 | %
Risk free interest rate |  |  | 4.70 | % |  |  | 4.70 | % |  |  | 4.70 | %
Number of investment options |  |  | 70,000 |  |  |  | 375,000 |  |  |  | 625,000 |
Value (per share) |  | $ | 1.01 |  |  | $ | 1.18 |  |  | $ | 1.18 |
The key inputs into the Weighted Expected Return valuation model for the Level 3 valuations of the derivative liability as of redemption, are below:
|  |  | May 2022 Derivative Liability |
Principal |  | $ | — |
Dividend rate |  |  | — | %
Market rate |  |  | — | %

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative liabilities at fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_StatementScenarioAxis=ENVB_SubsequentMeasurementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |